- Home
- SIF vs IGC Comparison
SIF vs IGC Comparison
Compare SIF & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- IGC
- Stock Information
- Founded
- SIF 1913
- IGC 2005
- Country
- SIF United States
- IGC United States
- Employees
- SIF N/A
- IGC N/A
- Industry
- SIF Office Equipment/Supplies/Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- IGC Health Care
- Exchange
- SIF Nasdaq
- IGC Nasdaq
- Market Cap
- SIF 34.9M
- IGC 33.5M
- IPO Year
- SIF N/A
- IGC N/A
- Fundamental
- Price
- SIF $7.00
- IGC $0.37
- Analyst Decision
- SIF
- IGC Strong Buy
- Analyst Count
- SIF 0
- IGC 2
- Target Price
- SIF N/A
- IGC $3.88
- AVG Volume (30 Days)
- SIF 33.9K
- IGC 862.4K
- Earning Date
- SIF 08-14-2025
- IGC 08-14-2025
- Dividend Yield
- SIF N/A
- IGC N/A
- EPS Growth
- SIF N/A
- IGC N/A
- EPS
- SIF N/A
- IGC N/A
- Revenue
- SIF $83,663,000.00
- IGC $1,327,000.00
- Revenue This Year
- SIF N/A
- IGC $15.26
- Revenue Next Year
- SIF N/A
- IGC $3.41
- P/E Ratio
- SIF N/A
- IGC N/A
- Revenue Growth
- SIF 35.71
- IGC 24.95
- 52 Week Low
- SIF $2.33
- IGC $0.25
- 52 Week High
- SIF $7.40
- IGC $0.48
- Technical
- Relative Strength Index (RSI)
- SIF 75.53
- IGC 57.43
- Support Level
- SIF $5.61
- IGC $0.35
- Resistance Level
- SIF $6.25
- IGC $0.37
- Average True Range (ATR)
- SIF 0.44
- IGC 0.02
- MACD
- SIF 0.12
- IGC -0.00
- Stochastic Oscillator
- SIF 86.93
- IGC 79.80
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.